- Home
- AKAN vs ISPC Comparison
AKAN vs ISPC Comparison
Compare AKAN & ISPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AKAN | ISPC |
|---|---|---|
| Founded | 2021 | 2009 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Precision Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0M | 2.2M |
| IPO Year | 2021 | 2020 |
Fundamental Metrics
Financial Performance| Metric | AKAN | ISPC |
|---|---|---|
| Price | $0.79 | $0.20 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 66.9K | ★ 8.7M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $9,291,115.00 |
| Revenue This Year | N/A | $35.93 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.42 | $0.18 |
| 52 Week High | $9.29 | $2.16 |
Technical Indicators
Market Signals| Indicator | AKAN | ISPC |
|---|---|---|
| Relative Strength Index (RSI) | 43.12 | 39.28 |
| Support Level | $0.42 | N/A |
| Resistance Level | $1.12 | $0.44 |
| Average True Range (ATR) | 0.09 | 0.04 |
| MACD | -0.00 | -0.00 |
| Stochastic Oscillator | 13.85 | 7.05 |
Price Performance
Historical ComparisonAbout AKAN Akanda Corp.
Akanda Corp is a cannabis cultivation, manufacturing, and distribution company. The company has three reportable segments: Cultivation, Distribution, and Corporate. A majority of its revenue is generated from the Distribution segment, which relates to the distribution of medical cannabis products, including cannabis oil and cannabis flower for medical use in the United Kingdom.
About ISPC iSpecimen Inc.
iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research, with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas; Europe, the Middle East, Africa, and Asia Pacific, which majority, comes from the Americas.